MAPS appoints Liana Gillooly and Andrew Mo Septimus to its Board of Directors, adding policy, philanthropy, and nonprofit leadership to psychedelic medicine governance

MAPS has added Liana Gillooly and Andrew Mo Septimus to its Board of Directors, expanding the organization's leadership with experience in public policy, philanthropy, nonprofit strategy, and institutional governance. The move signals continued professionalization at a prominent psychedelic nonprofit working at the intersection of advocacy, research, and public education. Gillooly and Septimus bring backgrounds likely relevant to fundraising, strategic oversight, and external relations as psychedelic organizations navigate regulatory change and growing mainstream visibility. Board appointments at MAPS matter because leadership composition can shape priorities in research support, public messaging, partnerships, and the broader transition of psychedelic medicine from activist roots toward more formal health and policy institutions.